Previous reports concerning isolation of CSCs from tumours and tumour cell lines have described the use of a range of stem-cell-related markers but expression of CD44, alone or together with additional markers, has been widely used for the identification of CSCs in breast, oral, prostate, colon and pancreatic malignancies [2], [3], [17]–[19]. This evidence concerns the gene CD44 and neoplasm.